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Raquel P. Herrera*a 
We report our results concerning the first squaramide-catalysed hydrophosphonylation of 
aldehydes. In all cases, the reactions proceeded smoothly and cleanly under mild reaction 
conditions rendering final α-hydroxy phosphonates in very good yields and high 
enantioselectivities. It is one of the scarce organocatalytic examples of this reaction using 
aldehydes. It is the first time that diphenylphosphite 1e has been successfully employed in a 
chiral Pudovik reaction with aldehydes, in contrast to the dialkylphosphites used in 
previously published procedures, extending the generality of this asymmetric methodology. 
 
Introduction 
Addition of dialkyl- and diphenylphosphites to carbonyl 
compounds (Pudovik reaction)1 is a powerful and widely 
applied strategy for the construction of C-P bonds, and a 
straightforward tool for providing efficient access to chiral α-
hydroxy phosphonates and their corresponding phosphonic 
acids.2 Interestingly, compounds bearing this motif have shown 
remarkable biological activities and are currently employed in 
the pharmaceutical industry (Scheme 1).3 The absolute 
configuration of these phosphonyl compounds could strongly 
influence their biological activities,4 and a growing interest in 
their asymmetric synthesis has been promoted during the last 
two decades. Several efficient enantioselective catalytic 
methods of hydrophosphonylation of aldehydes have been 
reported in the presence of a chiral metal complex giving access 
to α-hydroxy phosphonates with good outcomes.5,6 
 In addition to the extensive spectrum of biological 
properties exhibited by this kind of compounds (antibacterial, 
antivirus, antibiotic and pesticidal activities, as well as a potent 
antitumor agent),7 α-hydroxy phosphonates have also attracted 
attention as synthetic intermediates for preparing further α-8 and 
γ-functionalised9 phosphonates (Scheme 1). 
 
Scheme 1 Direct approach to appealing phosphonate derivatives 
 Although the Pudovik reaction with aldehydes has been the 
focus of intensive studies using chiral metal catalysts,2,5,6 the 
organocatalytic version of this appealing strategy has been 
overlooked in the literature. After the pioneering chiral 
organocatalytic example appeared in 1983,10 in which a scarce 
number of aldehydes (only two) was disclosed, requiring 
successive recrystallizations to improve the enantioselectivities, 
only a pivotal example of an organocatalysed approach has 
been published in 2009 by Ooi’s group.11 Our experience in the 
organocatalysed Pudovik reaction with imines12,13 and 
hydrazones,14 and the lack of background information on 
aldehydes encouraged us to explore the feasibility of catalysing 
this process with hydrogen bonding based catalysts, due to their 
well-known capacity to activate carbonyl compounds.15,16 In 
this communication, we report our appealing results concerning 
the first asymmetric squaramide-organocatalysed Pudovik 
reaction using aldehydes. 
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Results and discussion 
We started our investigation examining the viability of the 
addition of dibenzylphosphite (1a) to aldehyde 2a catalysed by 
chiral catalysts 3a-3c acting through hydrogen bonding 
(Scheme 2). Based on our own experience in the 
hydrophosphonylation reaction,12,14 we foresaw the importance 
of comprising a basic functionality in the catalyst structure, 
favouring a plausible bifunctional catalysis, since only model 
catalysts 3a-c afforded promising results, compared with simple 
thioureas.17 
 
Scheme 2 Model hydrophosphonylation reaction tested 
 To our delight, the initial screening of catalysts revealed 
squaramide 3c to be the best compromise in terms of both 
enantioselectivity and reactivity. However, before discarding 
thioureas 3a and 3b, we continued exploring these catalysts to 
verify if they worked better with other phosphites 1b-1e (Table 
1). 
Table 1. Screening of different phosphites 1b-e with catalysts 3a-c.a 
 
Entry R Cat. time (h) yield (%)b ee(%)c 
1d Me 3a 20 83 8 
2d Et 3a 18 90 14 
3d iPr 3a 48 83 14 
4d Ph 3a 72 30 18 
5 Me 3c 20 86 38 
6 Et 3c 24 n.d.e n.d.e 
7 iPr 3c 24 n.d.e n.d.e 
8 Ph  3c 20  83 46 
9 Ph  3b 48 57 25 
a Experimental conditions: To a mixture of catalyst 3a-c (0.02 mmol) and 
aldehyde 2a (0.1 mmol) in toluene (0.5 mL), phosphite 1b-e (0.2 mmol) was 
further added in a test tube at room temperature. After the reaction time, 
adducts 4 were isolated by flash chromatography. b Isolated yield. c 
Determined by chiral HPLC analysis. d Reaction performed using 0.2 mmol 
of aldehyde. e Not determined. 
 After examining the influence of diverse phosphites 1b-e in 
our reaction model, and although we did not observe reactivity 
with some of the phosphites investigated while using catalyst 
3c (entries 6 and 7), we found that diphenylphosphite (1e) led 
to the best results in terms of enantioselectivity and reactivity 
(entry 8). Subsequent to this exploration, we continued the 
study with squaramide 3c as the catalyst of choice and 
phosphite 1e for testing different key parameters such as type of 
solvent, temperature and concentration (Table 2). 
Table 2 Screening of the reaction conditions.a 
 
Entry Solvent (mL) Cat. 
(%) 
T 
(ºC) 
time  
(h) 
yield  
(%)b 
ee 
(%)c 
1 Xylene (0.5) 20 r.t. 24 92 50 
2 CH2Cl2 (0.5) 20 r.t. 24 97 62 
3 CH3Cl (0.5) 20 r.t. 24 81 60 
4 THF (0.5) 20 r.t. 24 94 62 
5 CH3CN (0.5) 20 r.t. 24 70 70 
6 1,4-Dioxane (0.5) 20 r.t. 24 n.r.d n.r.d 
7 Et2O (0.5) 20 r.t. 24 n.r.d n.r.d 
8 CH2Cl2 (0.5) 20 5 19 83 68 
9 CH2Cl2 (0.5) 20 -27 19 75 72 
10 CH3CN (0.5) 20 -27 72 80 79 
11 CH3CN (1) 20 -27 96 98 82 
12e CH3CN (1) 20 -27 83 71 82 
13 CH3CN (1) 10 -27 95 85 80 
14f CH3CN (0.5) 20 -38 52 85 87 
15 CH3CN (0.5) 20 -38 96 88 76 
16f CH3CN (0.5) 30 -38 52 97 86 
17 CH3CN (0.5) 10 -38 99 62 52 
a Experimental conditions: To a mixture of catalyst 3c (0.02 mmol) and 
aldehyde 2a (0.1 mmol) in the corresponding solvent, phosphite 1e (0.2 
mmol) was further added in a test tube at the temperature indicated. After the 
reaction time, adduct 4ea was isolated by flash chromatography. b Isolated 
yield. c Determined by chiral HPLC analysis (Chiralpak IA, flow 
hexane/AcOEt 70:30, 1 mL/min). d No reaction. e Reaction performed with 1 
equiv. of phosphite 1e. f Reaction performed in absence of stirring. 
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 Among all the studied solvents, we found CH3CN to be the 
best choice for this procedure in terms of enantioselectivity 
(entry 5), whereas no reaction was observed with some ethereal 
solvents such as 1,4-dioxane (entry 6) or Et2O (entry 7), having 
a negative influence on the activity of the catalyst. Furthermore, 
we were pleased to find that cooling the reaction mixture to -38 
ºC had a remarkable positive effect on the enantioselectivity of 
the process, without impairing the levels of reactivity (entry 
14). We did not decrease the temperature of the reaction any 
further since we were close to the m.p. of the solvent (-44 ºC). 
The dilution of the reaction also had a positive effect at -27 ºC 
on the enantioselectivity of the products (entry 9). Lowering the 
catalyst loading did not afford better results (entries 13 and 17) 
and although better yields are attained with a higher catalytic 
charge as expected (entry 16), we continued with a reasonable 
20 mol%. Surprisingly, we observed that performing the 
reaction at -38 ºC in absence of stirring afforded the best results 
in terms of enantioselectivity and reactivity (compare entries 14 
and 15). It seems that the insolubility of the product at this 
temperature is the driving force of the reaction, since in absence 
of stirring a big precipitate is observed at the bottom of the 
reaction tube. This fact resulted in better yields when compared 
with the same reaction performed at higher temperatures and it 
also had a clear positive effect on the enantioselectivity. With 
the optimised reaction conditions in hand, we extended our 
methodology to a broad range of different substituted aldehydes 
as shown in Table 3. 
Table 3. Scope of the squaramide-catalysed hydrophosphonylation reaction. 
P
H OPh
OPh
O
+ R H
O
P
OH
O
OPh
OPh
2a-k 4ea-ek
3c (20 mol%)
CH3CN, -38 ºC
R
1e  
Entry R Product time  
(h) 
yield  
(%)a 
ee 
(%)b 
1c 4-NO2Ph, 2a 4ea 95 98 88 
2 4-MePh, 2b 4eb 96 81 80 
3 1-Naphthyl, 2c 4ec 92 92 80 
4 Ph, 2d 4ed 92 82 81 
5 4-BrPh, 2e 4ee 92 72 84 
6 4-ClPh, 2f 4ef 88 80 82 
7 3-ClPh, 2g 4eg 88 98 80 
8c 4-CNPh, 2h 4eh 90 98 85 
9 PhCH2CH2, 2i 4ei 90  77 68 
10 Cy, 2j 4ej 92 98 75 
11 tBu, 2k 4ek 94 73 85 
a Isolated yield. b Determined by chiral HPLC. c Reaction performed in 1 mL 
of solvent. 
The addition reaction took place smoothly giving rise to the 
desired α-hydroxy phosphonates 4 in excellent yields (up to 
98%) and high enantioselectivities (up to 88%). The efficiency 
of the developed methodology is well accounted since it was 
successfully applied to all the aldehydes examined 2a-k. We 
could reach 88% and 85% of ee using aldehydes 2a and 2h, 
respectively, simply through slight modifications of the reaction 
conditions, using 1 mL of solvent instead of 0.5 mL (entries 1 
and 8). The electronic effects on the enantioselectivity and 
reactivity were explored using different meta- and para-
substituted benzaldehydes (entries 1-8). Neither the reactivity 
nor the enantioselectivity suggested a dependence on the 
electronic environment in the aromatic ring, as excellent results 
were accomplished with all of them. On the other hand, using 
aliphatic aldehydes, a clear dependence on steric hindrance 
could be observed (compare entries 9, 10 and 11), since better 
enantioselectivities were achieved with bulkier groups, that is 
from primary < secondary < tertiary carbon, although no 
correlation with the yield was revealed. In the case of aldehyde 
2k, it was necessary to cool the aldehyde before its addition in 
order to avoid its evaporation. Its volatility could justify the 
yield reached with this substrate (entry 11).  
 Since these final adducts have not been previously reported 
in the chiral version, in order to determine the absolute 
configuration of our products, single crystals were grown from 
adducts 4ee and 4eg. The stereochemical outcome was 
determined to be R for both final products (Figure 1).18 The 
same absolute configuration was assumed for all products 4. 
 
 
Fig. 1 X‐ray crystal structures of (R)‐4ee and (R)‐4eg. 
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Having demonstrated the capacity of squaramide 3c to 
efficiently catalyse the addition of diphenylphosphite 1e to 
aldehydes 2a-k, we propose the following reasonable transition 
state to explain the role of the catalyst based on previous modes 
of activation by this kind of structure (Figure 2).19 On the basis 
of the experimental results, we envisioned that the chiral 
squaramide 3c could act in a bifunctional fashion.20 On one 
hand, the aldehyde could be activated by the squaramide moiety 
through double hydrogen bonding with the NH groups. 
Simultaneously, the basic nitrogen atom on the pyrrolidine ring 
would activate the phosphonate form in the tautomeric 
equilibrium,21 driving the attack of the active phosphite form 
over the Re-face of the fixed aldehyde. This would afford the R 
absolute configuration in all final products, which is consistent 
with the observed results in our products.  
 
Fig. 2 Proposed mechanistic hypothesis 
Our developed methodology, if compared with the 
pioneering protocol described by Wynberg and co-workers,10,22 
has broader applicability. It is evident by the fact that our 
strategy is tolerant towards various functional groups including 
halides, nitro, cyano, naphthyl and alkyl groups. Additionally, 
the herein described method is a more straightforward protocol 
achieving the final goal in a simplest manner, without the 
necessity of subsequent derivatization or recrystallization in 
order to obtain high enantioslectivities. Further, our most 
accessible catalyst 3c compared with that used by Ooi and co-
workers and the development of the reaction at -38 ºC instead 
of at -98 ºC makes our procedure an attractive alternative.11a 
Conclusions 
In conclusion, we have demonstrated the ability of the chiral 
squaramide 3c to accomplish the addition of diphenylphosphite 
1e to a variety of aromatic 2a-h and aliphatic aldehydes 2i-k 
through a simple and general approach, with very good results 
in terms of enantioselectivity and reactivity. This protocol 
represents an additional extended organocatalytic procedure of 
hydrophosphonylation of aldehydes, with all reagents and 
catalyst being commercially available. Moreover, tedious or 
hazardous conditions, anhydrous solvents or reagents and inert 
atmosphere are not required as they are in the organometallic 
version. The potential of this methodology is demonstrated by 
its simplicity and generality which could become a key work in 
this area of research. Moreover, it is the first time, to the best of 
our knowledge, that diphenylphosphite 1e has been successfully 
employed in a chiral Pudovik reaction of aldehydes in contract 
to the other dialkylphosphites used in previously published 
procedures,2 extending the generality of this asymmetric 
methodology.23 
Experimental Section 
General Experimental Methods. Purification of reaction 
products was carried out by flash chromatography using silical-
gel (0.063-0.200 mm). Analytical thin layer chromatography 
was performed on 0.25 mm silical gel 60-F plates. ESI 
ionization method and mass analyser type MicroTof-Q were 
used for the HRMS measurements. 1H-NMR spectra were 
recorded at 300 MHz and 400 MHz; 13C-NMR spectra were 
recorded at 75 MHz and 100 MHz; CDCl3 as the solvent. 
Chemical shifts were reported in the δ scale relative to residual 
CHCl3 (7.26 ppm) for 1H-NMR and to the central line of CDCl3 
(77 ppm) for 13C-NMR. 
 
Materials. All commercially available solvents and reagents 
were used as received. The 1H and 13C NMR spectra for 
compounds 4eb,24 4ec,25 4ee,25 4eg,25  are consistent with 
values previously reported in the literature 
 
Representative procedure for squaramide-organocatalysed 
hydrophosphonylation reaction of aldehydes 
To a mixture of catalyst 3c (0.02 mmol), and aldehyde 2a-k 
(0.1 mmol) in CH3CN (0.5 mL), phosphite 1e (0.2 mmol) was 
further added in a test tube at –38 ºC. After the reaction time 
(see Table 3), adducts 4 were isolated by flash chromatography 
or medium pressure liquid chromatography (SiO2, 
hexane/EtOAc 7:3). Yields and enantioselectivities are reported 
in Table 3. 
 
(R)-Diphenyl hydroxy(4-nitrophenyl)methylphosphonate 
(4ea) 
Following the general procedure, compound 4ea was obtained 
after 95 h of reaction at –38 ºC as a white solid in 98% yield 
(37.7 mg). The ee of the product was determined to be 88% by 
HPLC using a Daicel Chiralpak IA column (n-hexane/AcOEt = 
70:30, flow rate 1 mL/min, λ = 268.3 nm): τmajor = 23.7 min; 
τminor = 20.7 min. M.p. 137-140 ºC. [α]D26 = +47 (c 0.40, CHCl3, 
80% ee). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.1 Hz, 
2H), 7.76 (dd, J = 2.4, 8.4 Hz, 2H), 7.27-7.31 (m, 4H), 7.16-
7.20 (m, 2H), 7.03-7.08 (m, 4H), 5.44 (dd, J = 4.8, 11.0 Hz, 
1H), 4.02 (dd, J = 5.3, 7.8 Hz, 1H). 13C NMR (75 MHz, CDCl3) 
δ 150.0 (d, J = 10.1 Hz, 1C), 149.9 (d, J = 10.6 Hz, 1C), 147.7 
(d, J = 4.0 Hz, 1C), 143.0 (d, J = 1.8 Hz, 1C), 129.9 (d, J = 6.6 
Hz, 4C), 128.0 (d, J = 1.8 Hz, 2C), 125.7 (d, J = 7.6 Hz, 2C), 
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123.4 (d, J = 2.8 Hz, 2C), 120.5 (d, J = 9.3 Hz, 2C), 120.4 (d, J 
= 9.3 Hz, 2C), 69.8 (d, J = 160.3 Hz, 1C). IR (KBr film) (cm–1) 
ν 3306, 2923, 2853, 1588, 1513, 1488, 1377, 1215, 1182, 945, 
761, 690. HRMS (ESI+) calcd C19H16NNaO6P 408.0613; found 
408.0607 [M+Na]. 
 
(R)-Diphenyl hydroxy(p-tolyl)methylphosphonate (4eb)24  
Following the general procedure, compound 4eb was obtained 
after 96 h of reaction at –38 ºC as a white solid in 81% yield 
(28.7 mg). The ee of the product was determined to be 80% by 
HPLC using a Daicel Chiralpak IC column (n-hexane/i-PrOH = 
90:10, flow rate 1 mL/min, λ = 262 nm): τmajor = 18.9 min; τminor 
= 16.8 min. [α]D28 = +27 (c 0.87, CHCl3, 74% ee). IR (KBr 
film) (cm–1) ν 3337, 2924, 2854, 1590, 1489, 1456, 1377, 1260, 
1241, 1212, 1190, 1163, 1071, 1022, 1040, 940, 800, 764, 689. 
HRMS (ESI+) calcd C20H19NaO4P 377.0919; found 377.0913 
[M+Na]. 
 
(R)-Diphenyl hydroxy(naphthalen-1-yl)methylphosphonate 
(4ec) 
Following the general procedure, compound 4ec was obtained 
after 92 h of reaction at –38 ºC as a white solid in 92% yield 
(35.9 mg). The ee of the product was determined to be 80% by 
HPLC using a Daicel Chiralpak IC column (n-hexane/i-PrOH = 
90:10, flow rate 1 mL/min, λ = 283.7 nm): τmajor = 21.5 min; 
τminor = 17.3 min. M.p. 110-112 ºC. [α]D26 = +98 (c 0.61, CHCl3, 
80% ee). 1H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 8.5 Hz, 
1H), 7.97 (dd, J = 3.4, 7.2 Hz, 1H), 7.85-7.90 (m, 2H), 7.49-
7.56 (m, 3H), 7.04-7.27 (m, 8H), 6.88-6.90 (m, 2H), 6.20 (dd, J 
= 3.8, 10.5 Hz, 1H), 3.56 (br s, 1H). 13C NMR (100 MHz, 
CDCl3) δ 150.3 (d, J = 10.3 Hz, 1C), 150.3 (d, J = 9.9 Hz, 1C), 
133.7 (d, J = 1.7 Hz, 1C), 131.5 (d, J = 1.8 Hz, 1C), 130.9 (d, J 
= 6.8 Hz, 1C), 129.6 (d, J = 14.5 Hz, 4C), 129.4 (d, J = 3.5 Hz, 
1C), 128.8 (d, J = 0.7 Hz, 1C), 126.5 (1C), 126.1 (d, J = 6.4 Hz, 
1C), 125.8 (1C), 125.4 (d, J = 3.5 Hz, 1C), 125.2 (d, J = 14.9 
Hz, 2C), 123.4 (1C), 120.4 (d, J = 22.4 Hz, 2C), 120.3 (d, J = 
22.4 Hz, 2C), 67.2 (d, J = 163.7 Hz, 1C). IR (KBr film) (cm–1) 
ν 3252, 2924, 2854, 1590, 1513, 1488, 1463, 1377, 1250, 1186, 
1161, 942, 804, 767, 688. HRMS (ESI+) calcd C23H19NaO4P 
413.0919; found 413.0913 [M+Na]. 
 
(R)-Diphenyl hydroxy(phenyl)methylphosphonate (4ed)25 
Following the general procedure, compound 4ed was obtained 
after 92 h of reaction at –38 ºC in 82% yield (27.9 mg). The ee 
of the product was determined to be 81% by HPLC using a 
Daicel Chiralpak IC column (n-hexane/i-PrOH = 90:10, flow 
rate 1 mL/min, λ = 261.2 nm): τmajor = 16.9 min; τminor = 14.4 
min. [α]D28 = +21 (c 0.35, CHCl3, 79% ee). 
 
(R)-Diphenyl (4-bromophenyl)(hydroxy)methylphosphonate 
(4ee) 
Following the general procedure, compound 4ee was obtained 
after 92 h of reaction at –38 ºC as a white solid in 72% yield 
(30.2 mg). The ee of the product was determined to be 84% by 
HPLC using a Daicel Chiralpak IA column (n-hexane/ i-PrOH 
= 90:10, flow rate 1 mL/min, λ = 260.7 nm): τmajor = 21.1 min; 
τminor = 19.3 min. M.p. 128-130 ºC. [α]D23 = +29 (c 0.47, CHCl3, 
83% ee). 1H NMR (400 MHz, CDCl3) δ 7.49-7.51 (m, 2H), 
7.42-7.46 (m, 2H), 7.25-7.30 (m, 4H), 7.13-7.19 (m, 2H), 7.06-
7.08 (m, 2H), 7.01-7.03 (m, 2H), 5.25 (d, J = 9.3 Hz, 1H). 13C 
NMR (100 MHz, CDCl3) δ 150.2 (d, J = 10.4 Hz, 1C), 150.1 
(d, J = 11.1 Hz, 1C), 134.8 (1C), 131.5 (d, J = 2.6 Hz, 2C), 
129.7 (d, J = 8.3 Hz, 4C), 129.0 (d, J = 6.1 Hz, 2C), 125.3 (d, J 
= 10.4 Hz, 2C), 122.5 (d, J = 4.3 Hz, 2C), 120.5 (d, J = 4.6 Hz, 
2C), 120.5 (d, J = 4.8 Hz, 2C), 69.9 (d, J = 161.9 Hz, 1C). IR 
(KBr film) (cm–1) ν 3319, 2924, 2854, 1730, 1589, 1511, 1487, 
1462, 1403, 1377, 1242, 1212, 1189, 1163, 1101, 1070, 1043, 
1025, 1010, 942, 823, 766, 730, 689, 616, 581, 442. HRMS 
(ESI+) calcd C19H16BrNaO4P 440.9867; found 440.9862 
[M+Na]. 
 
(R)-Diphenyl (4-chlorophenyl)(hydroxy)methylphosphonate 
(4ef)25 
Following the general procedure, compound 4ef was obtained 
after 88 h of reaction at –38 ºC as a white solid in 80% yield 
(30 mg). The ee of the product was determined to be 82% by 
HPLC using a Daicel Chiralpak IC column (n-hexane/i-PrOH = 
98:2, flow rate 1 mL/min, λ = 261.3 nm): τmajor = 12.2 min; 
τminor = 10.3 min. [α]D28 = +18 (c 0.32, CHCl3, 78% ee). IR 
(KBr film) (cm–1) ν 3313, 2924, 2853, 1589, 1489, 1457, 1377, 
1185, 1162, 1014, 759, 687. 
 
(R)-Diphenyl (3-chlorophenyl)(hydroxy)methylphosphonate 
(4eg) 
Following the general procedure, compound 4eg was obtained 
after 88 h of reaction at –38 ºC as a white solid in 98% yield 
(36.7 mg). The ee of the product was determined to be 80% by 
HPLC using a Daicel Chiralpak IC column (n-hexane/i-PrOH = 
95:5, flow rate 1 mL/min, λ = 272.6 nm): τmajor = 21.7 min; 
τminor = 16.5 min. M.p. 154-156 ºC.  [α]D28 = +26 (c 0.33, 
CHCl3, 77% ee). 1H NMR (400 MHz, CDCl3) δ 7.60-7.61 (m, 
1H), 7.46-7.51 (m, 1H), 7.26-7.35 (m, 6H), 7.15-7.21 (m, 2H), 
7.04-7.11 (m, 4H), 5.35 (dd, J = 5.0, 9.6 Hz, 1H), 3.46 (dd, J = 
5.1, 10.0 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 150.2 (d, J = 
10.0 Hz, 1C), 150.1 (d, J = 10.2 Hz, 1C), 137.4 (d, J = 2.2 Hz, 
1C), 134.4 (d, J = 3.0 Hz, 1C), 129.7 (d, J = 4.4 Hz, 4C), 129.7 
(1C), 128.7 (d, J = 3.4 Hz, 1C), 127.5 (d, J = 6.3 Hz, 1C), 125.5 
(d, J = 5.8 Hz, 1C), 125.4 (d, J = 5.3 Hz, 2C), 120.5 (d, J = 6.6 
Hz, 2C), 120.5 (d, J = 6.6 Hz, 2C), 70.1 (d, J = 160.8 Hz, 1C). 
IR (KBr film) (cm–1) ν 3343, 2924, 2853, 1723, 1589, 1490, 
1456, 1377, 1252, 1240, 1208, 1196, 1184, 1166, 1099, 1071, 
1010, 960, 938, 808, 769, 759, 690. HRMS (ESI+) calcd 
C19H16ClNaO4P 397.0372; found 397.0367 [M+Na]. 
 
(R)-Diphenyl (4-cyanophenyl)(hydroxy)methylphosphonate 
(4eh) 
Following the general procedure, compound 4eh was obtained 
after 90 h of reaction at –38 ºC as a white solid in 98% yield 
(35.8 mg). The ee of the product was determined to be 85% by 
HPLC using a Daicel Chiralpak IA column (n-hexane/i-PrOH = 
90:10, flow rate 1 mL/min, λ = 236.4 nm): τmajor = 31.7 min; 
τminor = 27.8 min. M.p. 124-126 ºC. [α]D30 = +51 (c 1.31, CHCl3, 
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82% ee). 1H NMR (400 MHz, CDCl3) δ 7.64-7.70 (m, 4H), 
7.26-7.31 (m, 4H), 7.15-7.20 (m, 2H), 7.01-7.06 (m, 4H), 5.34 
(dd, J = 5.1, 10.7 Hz, 1H), 4.52 (t, J = 6.4 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) δ 150.0 (d, J = 13.4 Hz, 1C), 149.9 (d, J = 
13.9 Hz, 1C), 140.8 (d, J = 2.4 Hz, 1C), 132.1 (d, J = 2.9 Hz, 
2C), 129.8 (d, J = 7.2 Hz, 4C), 127.9 (d, J = 5.7 Hz, 2C), 125.6 
(d, J = 9.8 Hz, 2C), 120.4 (d, J = 4.2 Hz, 2C), 120.4 (d, J = 4.1 
Hz, 2C), 118.5 (d, J = 2.2 Hz, 1C), 112.2 (d, J = 3.8 Hz, 1C), 
70.0 (d, J = 159.8 Hz, 1C). IR (KBr film) (cm–1) ν 3319, 2924, 
2854, 2225, 1641, 1529, 1491, 1462, 1377, 1245, 1208, 1184, 
1069, 940, 757, 685. HRMS (ESI+) calcd C20H16NNaO4P 
388.0715; found 388.0709 [M+Na]. 
 
(R)-Diphenyl 1-hydroxy-3-phenylpropylphosphonate (4ei) 
Following the general procedure, compound 4ei was obtained 
as a white solid after 90 h of reaction at –38 ºC as a white solid 
in 77% yield (28.4 mg). The ee of the product was determined 
to be 68% by HPLC using a Daicel Chiralpak IA column (n-
hexane/i-PrOH = 90:10, flow rate 1 mL/min, λ = 261.2 nm): 
τmajor = 13.1 min; τminor = 14.7 min. M.p. 108-110 ºC. [α]D25 = –
6.8 (c 1.02, CHCl3, 67% ee). 1H NMR (400 MHz, CDCl3) δ 
7.12-7.32 (m, 15H), 4.15-4.19 (m, 1H), 3.16 (br s, 1H), 2.98-
3.04 (m, 1H), 2.77-2.85 (m, 1H), 2.17-2.32 (m, 2H). 13C NMR 
(100 MHz, CDCl3) δ 150.3 (d, J = 9.1 Hz, 1C), 150.2 (d, J = 
10.0 Hz, 1C), 140.9 (1C), 129.8 (4C), 128.6 (d, J = 13.0 Hz, 
4C), 126.2 (1C), 125.3 (d, J = 5.0 Hz, 1C), 125.3 (d, J = 4.9 Hz, 
1C), 120.7 (d, J = 5.9 Hz, 2C), 120.7 (d, J = 5.9 Hz, 2C), 66.8 
(d, J = 160.6 Hz, 1C), 33.0 (d, J = 2.0 Hz, 1C), 31.6 (d, J = 15.0 
Hz, 1C).  IR (KBr film) (cm–1) ν 3338, 3062, 3026, 2926, 2856, 
2225, 1591, 1490, 1454, 1188, 1162, 1070, 1025, 1008, 941, 
762, 689. HRMS (ESI+) calcd C21H21NaO4P 391.1075; found 
391.1070 [M+Na].´ 
 
(R)-Diphenyl cyclohexyl(hydroxy)methylphosphonate (4ej) 
Following the general procedure, compound 4ej was obtained 
after 92 h of reaction at –38 ºC as a white solid in 98% yield 
(33.9 mg). The ee of the product was determined to be 75% by 
HPLC using a Daicel Chiralpak IA column (n-hexane/i-PrOH = 
95:5, flow rate 1 mL/min, λ = 262.4 nm): τmajor = 22.1 min; 
τminor = 26.2 min. M.p. 100-102 ºC. [α]D26 = –3 (c 0.96, CHCl3, 
69% ee). 1H NMR (400 MHz, CDCl3) δ 7.29-7.34 (m, 4H), 
7.15-7.21 (m, 6H), 4.02 (q, J = 5.7, 12.8 Hz, 1H), 2.47 (dd, J = 
6.5, 7.2 Hz, 1H), 2.10-2.13 (m, 1H), 1.95-2.06 (m, 1H), 1.88-
1.91 (m, 1H), 1.79-1.81 (m, 2H), 1.66-1.70 (m, 1H), 1.13-1.46 
(m, 5H). 13C NMR (100 MHz, CDCl3) δ 150.3 (d, J = 10.1 Hz, 
1C), 150.2 (d, J = 9.8 Hz, 1C), 129.7 (d, J = 5.7 Hz, 4C), 125.2 
(m, 2C), 120.6 (d, J = 4.0 Hz, 2C), 120.6 (d, J = 4.0 Hz, 2C), 
72.6 (d, J = 155.1 Hz, 1C), 39.8 (d, J = 2.4 Hz, 1C),  29.9 (d, J 
= 9.5 Hz, 1C),  27.9 (d, J = 7.6 Hz, 1C), 26.1 (1C), 25.9 (d, J = 
17.6 Hz, 2C). IR (KBr film) (cm–1) ν 3325, 2932, 2852, 1591, 
1487, 1448, 1408, 1193, 1161, 1106, 1070, 1003, 972, 935, 
802, 774, 690, 661, 475. HRMS (ESI+) calcd C19H23NaO4P 
369.1232; found 369.1226 [M+Na]. 
 
 
(R)-Diphenyl-1-hydroxy-2,2-dimethylpropylphosphonate 
(4ek) 
Following the general procedure, compound 4ek was obtained 
after 94 h of reaction at –38 ºC as a white solid in 73% yield 
(23.4 mg). The ee of the product was determined to be 85% by 
HPLC using a Daicel Chiralpak IA column (n-hexane/ i-PrOH 
= 98:2, flow rate 1 mL/min,  = 262.4 nm): τmajor = 28.2 min; 
τminor = 32.6 min. M.p. 116-120 ºC. [α]D25 = +7 (c 0.47, acetone, 
84% ee). 1H NMR (400 MHz, CDCl3) δ 7.28-7.34 (m, 4H), 
7.14-7.20 (m, 6H), 3.92 (dd, J = 6.4, 7.2 Hz, 1H), 2.59 (dd, J = 
6.8, 7.8 Hz, 1H), 1.22 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 
150.3 (d, J = 22.2 Hz, 1C), 150.2 (d, J = 21.9 Hz, 1C), 129.7 (d, 
J = 7.6 Hz, 4C), 125.2 (d, J = 3.5 Hz, 1C), 125.1 (d, J = 3.5 Hz, 
1C),  120.6 (d, J = 4.0 Hz, 2C),  120.6 (d, J = 4.1 Hz, 2C),  76.3 
(d, J = 152.5 Hz, 1C), 35.0 (d, J = 3.6 Hz, 1C), 26.7 (d, J = 6.7 
Hz, 3C). IR (KBr film) (cm–1) ν 3357, 2924, 2854, 1590, 1490, 
1462, 1377, 1246, 1205, 1189, 1161, 1064, 945, 903, 802, 766, 
690. HRMS (ESI+) calcd C17H21NaO4P 343.1075; found 
343.1070 [M++Na]. 
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